USP13 Facilitates the Proliferation of Hepatocellular Carcinoma Cells by Reducing K48 /63‐Linked Polyubiquitination and Degradation of PRPF6
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yanyu Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ubiquitination, Ubiquitin-Specific Proteases. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital project of Affiliated Hospital of Xuzhou Medical University, Jiangsu Provincial Medical Key Discipline, Xuzhou Institute of Technology.
Abstract (Originalsprache)
Ubiquitin‐specific peptidase 13 (USP13) is a well‐characterised deubiquitinating enzyme that plays a critical role in the pathogenesis and progression of various human malignancies. However, the precise mechanisms by which USP13 influences hepatocellular carcinoma (HCC) cell proliferation remain to be fully elucidated. In this study, we confirmed that USP13 expression was upregulated in HCC and correlated with poor prognosis. Further investigation revealed that the knockout of USP13 inhibited HCC cell proliferation, whereas overexpression of USP13 had the opposite effect. Mechanistically, pre‐mRNA processing factor 6 (PRPF6) was identified as a potential substrate of USP13 through mass spectrometry analysis. USP13 stabilised the PRPF6 protein by reducing its K48/63‐linked polyubiquitination levels and degradation. Ultimately, we demonstrated that the USP13‐PRPF6 axis promoted HCC cell proliferation was closely associated with the activation of the AKT‐mTOR signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Anesthesiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
ORCID-Profile: Zhiyi Liu
Förderung
- Hospital project of Affiliated Hospital of Xuzhou Medical University
- Jiangsu Provincial Medical Key Discipline
- Xuzhou Institute of Technology
- Advanced Program of The Affiliated Hospital of Xuzhou Medical University
- Basic Research Program of Jiangsu Province
- High level hospital construction project in Jiangsu Province
Zitieren
APA
Jiang, Y., Luo, Q., Zhang, X., Yang, W., Wang, R., Hu, Q., Liu, Z., & Zhang, B. (2025). USP13 Facilitates the Proliferation of Hepatocellular Carcinoma Cells by Reducing K48 /63‐Linked Polyubiquitination and Degradation of PRPF6. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70551
Vancouver
Jiang Y, Luo Q, Zhang X, Yang W, Wang R, Hu Q, et al. USP13 Facilitates the Proliferation of Hepatocellular Carcinoma Cells by Reducing K48 /63‐Linked Polyubiquitination and Degradation of PRPF6. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70551
BibTeX
@article{Jiang2025,
author = {Jiang, Yanyu and Luo, Qing and Zhang, Xuanchao and Yang, Weichao and Wang, Renhao and Hu, Qinghe and Liu, Zhiyi and Zhang, Bin},
title = {USP13 Facilitates the Proliferation of Hepatocellular Carcinoma Cells by Reducing K48 /63‐Linked Polyubiquitination and Degradation of PRPF6},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70551}
}
EUVIMED